Alba Abril Molina , Manuel Villa Gil Ortega , José Eduardo López Haldón , Isabel Merino González , Carmen Federero Fernández , Almudena Aguilera Saborido , Ana López Suárez , Mónica Fernández Quero , Agustín Guisado Rasco , Rosa Cardenal Piris , José Francisco Díaz Fernández
{"title":"多瓣疾病的经皮治疗:严重的主动脉和二尖瓣反流。复杂的病人,复杂的解决方案","authors":"Alba Abril Molina , Manuel Villa Gil Ortega , José Eduardo López Haldón , Isabel Merino González , Carmen Federero Fernández , Almudena Aguilera Saborido , Ana López Suárez , Mónica Fernández Quero , Agustín Guisado Rasco , Rosa Cardenal Piris , José Francisco Díaz Fernández","doi":"10.1016/j.crmic.2025.100098","DOIUrl":null,"url":null,"abstract":"<div><div>The case of a 77-year-old male with decompensated heart failure due to multivalve disease is presented: severe primary aortic regurgitation (tissue defect, without calcification) and severe mixed mitral regurgitation (functional and ruptured chordae tendineae). Due to severe left ventricle dysfunction and high surgical risk, a combined percutaneous treatment was performed successfully although very technically demanding (TAVI in TAVI and two Mitraclip devices).</div><div>Multivalvular disease is associated with worse prognosis, difficult diagnosis and therapeutic challenges.<sup>1</sup> Therefore, an individual assessment of each patient by a heart team, a comprehensive treatment planning and the experience and skill of the operators to handle any unforeseen issues are essential for success.</div></div>","PeriodicalId":100217,"journal":{"name":"Cardiovascular Revascularization Medicine: Interesting Cases","volume":"9 ","pages":"Article 100098"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Percutaneous treatment of multivalve disease: severe aortic and mitral regurgitation. Complex patient, complex solution\",\"authors\":\"Alba Abril Molina , Manuel Villa Gil Ortega , José Eduardo López Haldón , Isabel Merino González , Carmen Federero Fernández , Almudena Aguilera Saborido , Ana López Suárez , Mónica Fernández Quero , Agustín Guisado Rasco , Rosa Cardenal Piris , José Francisco Díaz Fernández\",\"doi\":\"10.1016/j.crmic.2025.100098\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>The case of a 77-year-old male with decompensated heart failure due to multivalve disease is presented: severe primary aortic regurgitation (tissue defect, without calcification) and severe mixed mitral regurgitation (functional and ruptured chordae tendineae). Due to severe left ventricle dysfunction and high surgical risk, a combined percutaneous treatment was performed successfully although very technically demanding (TAVI in TAVI and two Mitraclip devices).</div><div>Multivalvular disease is associated with worse prognosis, difficult diagnosis and therapeutic challenges.<sup>1</sup> Therefore, an individual assessment of each patient by a heart team, a comprehensive treatment planning and the experience and skill of the operators to handle any unforeseen issues are essential for success.</div></div>\",\"PeriodicalId\":100217,\"journal\":{\"name\":\"Cardiovascular Revascularization Medicine: Interesting Cases\",\"volume\":\"9 \",\"pages\":\"Article 100098\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-08-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiovascular Revascularization Medicine: Interesting Cases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2950275625000449\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Revascularization Medicine: Interesting Cases","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2950275625000449","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Percutaneous treatment of multivalve disease: severe aortic and mitral regurgitation. Complex patient, complex solution
The case of a 77-year-old male with decompensated heart failure due to multivalve disease is presented: severe primary aortic regurgitation (tissue defect, without calcification) and severe mixed mitral regurgitation (functional and ruptured chordae tendineae). Due to severe left ventricle dysfunction and high surgical risk, a combined percutaneous treatment was performed successfully although very technically demanding (TAVI in TAVI and two Mitraclip devices).
Multivalvular disease is associated with worse prognosis, difficult diagnosis and therapeutic challenges.1 Therefore, an individual assessment of each patient by a heart team, a comprehensive treatment planning and the experience and skill of the operators to handle any unforeseen issues are essential for success.